» Articles » PMID: 18381075

Establishment of the Culture Model System That Reflects the Process of Terminal Differentiation of Connective Tissue-type Mast Cells

Abstract

To understand physiological roles of tissue mast cells, we established a culture system where bone marrow-derived immature mast cells differentiate into the connective tissue-type mast cell (CTMC)-like cells through modifying the previous co-culture system with Swiss 3T3 fibroblasts. Our system was found to reproducibly mimic the differentiation of CTMCs on the basis of several criteria, such as granule maturation and sensitivity to cationic secretagogues. The gene expression profile obtained by the microarray analyses was found to reflect many aspects of the differentiation. Our system is thus helpful to gain deeper insights into terminal differentiation of CTMCs.

Citing Articles

Mast cell tolerance in the skin microenvironment to commensal bacteria is controlled by fibroblasts.

Di Nardo A, Chang Y, Alimohammadi S, Masuda-Kuroki K, Wang Z, Sriram K Cell Rep. 2023; 42(5):112453.

PMID: 37120813 PMC: 10290424. DOI: 10.1016/j.celrep.2023.112453.


Roles of IgE and Histamine in Mast Cell Maturation.

Tanaka S, Furuta K Cells. 2021; 10(8).

PMID: 34440939 PMC: 8392195. DOI: 10.3390/cells10082170.


Bone marrow derived mast cells injected into the osteoarthritic knee joints of mice induced by sodium monoiodoacetate enhanced spontaneous pain through activation of PAR2 and action of extracellular ATP.

Habuchi H, Izumi M, Dan J, Ushida T, Ikeuchi M, Takeuchi K PLoS One. 2021; 16(6):e0252590.

PMID: 34086763 PMC: 8177436. DOI: 10.1371/journal.pone.0252590.


Eucalyptus oil reduces allergic reactions and suppresses mast cell degranulation by downregulating IgE-FcεRI signalling.

Nakamura T, Yoshida N, Yamanoi Y, Honryo A, Tomita H, Kuwabara H Sci Rep. 2020; 10(1):20940.

PMID: 33262354 PMC: 7708995. DOI: 10.1038/s41598-020-77039-5.


Anti-ORAI1 antibody DS-2741a, a specific CRAC channel blocker, shows ideal therapeutic profiles for allergic disease via suppression of aberrant T-cell and mast cell activation.

Aki A, Tanaka K, Nagaoka N, Kimura T, Baba D, Onodera Y FASEB Bioadv. 2020; 2(8):478-488.

PMID: 32821879 PMC: 7429349. DOI: 10.1096/fba.2020-00008.